Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Blank

Showing results (381-390 of 387) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 387 results.
The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.
Nature Chemical Biology|January 30, 2019
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patientJean Quancard, Theo Klein, Shan-Yu Fung, et al.
The New England Journal of Medicine|February 27, 2004
Infliximab maintenance therapy for fistulizing Crohn's diseaseBruce E Sands, Frank H Anderson, Charles N Bernstein, et al.
The New England Journal of Medicine|December 14, 2016
Ustekinumab as Induction and Maintenance Therapy for Crohn's DiseaseBrian G Feagan, William J Sandborn, Christopher Gasink, et al.
Terapevticheskii Arkhiv|December 8, 2011
[Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease]L V Kolobukhina, L N Merkulova, M Iu Shchelkanov, et al.
The American Journal of Cardiology|July 17, 2022
Risk of Cardiovascular Events After COVID-19Larisa G Tereshchenko, Adam Bishop, Nora Fisher-Campbell, et al.
Molecular & Cellular Proteomics : MCP|June 15, 2013
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012Nancy Leymarie, Paula J Griffin, Karen Jonscher, et al.
Pageof 39

Showing results (381-390 of 387) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 387 results.
The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.
Nature Chemical Biology|January 30, 2019
An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patientJean Quancard, Theo Klein, Shan-Yu Fung, et al.
The New England Journal of Medicine|February 27, 2004
Infliximab maintenance therapy for fistulizing Crohn's diseaseBruce E Sands, Frank H Anderson, Charles N Bernstein, et al.
The New England Journal of Medicine|December 14, 2016
Ustekinumab as Induction and Maintenance Therapy for Crohn's DiseaseBrian G Feagan, William J Sandborn, Christopher Gasink, et al.
Terapevticheskii Arkhiv|December 8, 2011
[Pandemic influenza in Russia: specific features of clinical course and the absence of early etiotropic therapy as a risk factor of severe forms of the disease]L V Kolobukhina, L N Merkulova, M Iu Shchelkanov, et al.
The American Journal of Cardiology|July 17, 2022
Risk of Cardiovascular Events After COVID-19Larisa G Tereshchenko, Adam Bishop, Nora Fisher-Campbell, et al.
Molecular & Cellular Proteomics : MCP|June 15, 2013
Interlaboratory study on differential analysis of protein glycosylation by mass spectrometry: the ABRF glycoprotein research multi-institutional study 2012Nancy Leymarie, Paula J Griffin, Karen Jonscher, et al.
Pageof 39